Literature DB >> 33414546

Exploiting KRAS-mediated metabolic reprogramming as a therapeutic target.

Sanne Bootsma1,2, Sanne M van Neerven1,2, Louis Vermeulen3,4.   

Abstract

Entities:  

Year:  2021        PMID： 33414546     DOI： 10.1038/s41588-020-00758-y

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  2 in total

1.  Multivariate Risk Analysis of RAS, BRAF and EGFR Mutations Allelic Frequency and Coexistence as Colorectal Cancer Predictive Biomarkers.

Authors:  Adriana Ionescu; Liviu Bilteanu; Ovidiu Ionut Geicu; Florin Iordache; Loredana Stanca; Aurelia Magdalena Pisoschi; Adrian Miron; Andreea Iren Serban; Valentin Calu
Journal:  Cancers (Basel)       Date:  2022-06-04       Impact factor: 6.575

2.  Zebrafish Avatars of rectal cancer patients validate the radiosensitive effect of metformin.

Authors:  Bruna Costa; Laura M Fernandez; Oriol Parés; Ricardo Rio-Tinto; Inês Santiago; Mireia Castillo-Martin; Amjad Parvaiz; Rita Fior
Journal:  Front Oncol       Date:  2022-09-28       Impact factor: 5.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.